Serodus ASA Share Price

Stocks

03/17/03	Serodus : Primary endpoint reached by SER150 Phase 2a study in Diabetic Nephropathy.	PU
08/16/08	Serodus : Q&A delisting from Oslo Axess	PU
23/16/23	Serodus : Extraordinary general meeting held	PU
23/16/23	Serodus : Viggo Harboe Holding 2006 ApS announces results of voluntary offer	PU
02/16/02	Serodus : Viggo Harboe Holding 2006 Aps Launces voluntary offer for outstanding shares in Serodus ASA – Acceptance period starting 31 October 2016	PU

1 day

-5.56%

Manager	Title	Age	Since
Arnstein Gunnestad Endresen CEO	Chief Executive Officer	73	01/01/2023
Henrik Mordhorst DFI	Director of Finance/CFO	-	01/10/2019
Daniel Capion PRN	Corporate Officer/Principal	-	01/01/2021

Director	Title	Age	Since
Søren Elmann Ingerslev CHM	Chairman	-	01/01/2017
Terri Sebree BRD	Director/Board Member	68	01/04/2014
Viggo Gunnersen Harboe BRD	Director/Board Member	80	01/01/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SERODUS ASA	-5.56%	+7.94%	-	-	0
WUXI APPTEC CO., LTD.	+8.49%	+20.55%	+69.74%	+109.30%	6.81TCr
ARGENX SE	+1.25%	+2.44%	+32.55%	+72.63%	5.52TCr
INSMED INCORPORATED	-1.09%	+32.96%	+19.95%	+499.45%	2.86TCr
BIONTECH SE	+2.72%	+3.41%	-15.88%	-4.90%	2.35TCr
WUXI BIOLOGICS (CAYMAN) INC.	+10.83%	+18.38%	+52.76%	+4.58%	2.4TCr
GENMAB A/S	+6.50%	+7.56%	+38.20%	-21.33%	1.84TCr
PHARMAESSENTIA CORPORATION	-3.88%	+16.98%	+199.30%	+354.30%	1.58TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.20%	+11.51%	+34.94%	+681.88%	1.64TCr
EXELIXIS, INC.	+3.58%	+1.96%	+44.61%	+167.01%	1.34TCr
Average	+2.90%	+11.68%	+52.91%	+206.99%	2.93TCr
Weighted average by Cap.	+4.36%	+13.10%	+49.48%	+168.49%

Employees

Sector